Skip to main content

Table 2 Calculated Combination Indexes for human breast cancer (MDA-MB-231) cells treated with paclitaxel, doxorubicin or cyclophosphamide in combination with TTFields.

From: Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)

 

Combination index

 

MDA-MB-231 cells

TTFields intensity

(V/cm)

Paclitaxel

Doxorubicin

Cyclophosphamide

 

CI40

CI50

CI50

0.625

-

-

0.74

1.25

0.97

0.99

0.84

1.75

0.86

0.98

0.95